Trial intelligence / Profile preview

Pilot study of aripiprazole for antipsychotic-induced hyperprolactinaemia in young patients with severe mental illness and learning disabilities

2009-011228-73Phase 4Completed

Sponsor
University of Oxford
Start
Mar 2010
Modality
Small Molecules
Countries
1
01

Overview

Phase 4, single-arm trial of aripiprazole in hyperprolactinemia, Hypogonadism and low bone mineral density, sponsored by University of Oxford. Started Mar 2010; status: completed.

02

Drugs

aripiprazole
03

Conditions

hyperprolactinemiaHypogonadismlow bone mineral density

Beyond the preview

Go deeper on 2009-011228-73.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2009-011228-73.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call